Capitol Health

Capitol Health EBITDA Margin

Delisted

The EBITDA Margin of Capitol Health (CAJ.AX) as of Nov 6, 2026 is 12.19 %. In the previous year, EBITDA Margin was 19.32 % — a change of -36.88% (lower).

EBITDA Margin

12.19 %

YoY

-36.88%

Last updated:

EBITDA Margin of Capitol Health is 2024 12.19 % . EBITDA Margin of Capitol Health was 2023 19.32 % . It decreases by -36.88% lower compared to the previous year.

The Capitol Health EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2017
8.34 AUD
Jan 1, 2018
18.40 AUD
Jan 1, 2019
15.28 AUD
Jan 1, 2020
23.64 AUD
Jan 1, 2021
27.02 AUD
Jan 1, 2022
22.40 AUD
Jan 1, 2023
19.32 AUD
Jan 1, 2024
12.19 AUD
The Capitol Health EBITDA Margin history
YEAREBITDA MarginYoY
12.19 %-36.88%
19.32 %-13.78%
22.40 %-17.09%
27.02 %+14.30%
23.64 %+54.74%
15.28 %-16.98%
18.40 %+120.65%
8.34 %-26.87%
11.40 %-42.04%
19.68 %+33.52%
14.74 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Capitol Health Stock analysis

What does Capitol Health do? Capitol Health Ltd operates diagnostic imaging clinics across Australia under brands including Capital Radiology, Imaging at Olympic Park, Radiology Tasmania, Fowler Simmons Radiology, Women’s Imaging, and Direct Radiology. The company generates revenue by providing diagnostic imaging services such as general X-rays, ultrasounds, CT scans, MRI, mammography, echocardiography, nuclear medicine, cardiac imaging, and musculoskeletal procedures to patients requiring these medical services. Its clinics, totaling approximately 63 locations in Victoria, Tasmania, Western Australia, and South Australia, serve patients seeking diagnostic imaging and interventional care. The firm focuses on delivering specialized medical imaging solutions through its established brand portfolio. The company’s revenue streams come from direct patient services at its clinics, with services categorized into general imaging, specialized procedures, and diagnostic modalities. Patients requiring medical imaging for diagnosis or treatment are the primary customers, utilizing the full range of services offered under Capitol Health’s brand names. The clinics operate in multiple Australian states, with a concentration in Victoria and Tasmania, serving both general and specialized healthcare needs. Capitol Health Ltd’s business model centers on providing comprehensive diagnostic imaging services through its network of clinics, with each location operating under distinct brand names to target specific patient segments. The company’s revenue is derived from the delivery of medical imaging services across various specialties, including radiology, women’s health, and musculoskeletal care, all managed under its operational structure. The firm’s service offerings are designed to meet the diagnostic needs of patients requiring interventional and specialized imaging procedures. Capitol Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Capitol Health stock

EBITDA Margin of Capitol Health is 12.19 % in 2024.

EBITDA Margin of Capitol Health changed from 19.32 % to 12.19 %, representing a -36.88% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Capitol Health since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Capitol Health with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Capitol Health

All Key Metrics — Capitol Health